Skip to main content
See every side of every news story
Published • loading... • Updated

Centre proposes tighter regulatory oversight of antimicrobials to tackle drug resistance

Manufacturers would need central approval first as the ministry says weaker scrutiny has fueled safety risks and antimicrobial resistance.

  • On Thursday, the Union Health Ministry proposed amending the New Drugs and Clinical Trials Rules, 2019, to bring antimicrobials under Central regulatory oversight through draft Gazette Notification G.S.R. 983 .
  • Mounting concerns regarding antimicrobial resistance prompted the regulatory shift, as the Ministry flagged that antimicrobial products currently receive manufacturing licenses without adequate scrutiny, including bioavailability and stability studies.
  • Separately, the Ministry proposed amendments to the Drugs Rules, 1945, introducing Form 19-BC and Form 20-BC for wholesale bulk drugs to strengthen supply chain accountability and oversight.
  • Under the proposed framework, manufacturers must obtain permission from the Central Licensing Authority before applying for a license from the State Licensing Authority , strengthening central oversight.
  • The Central Government issued a draft notification on November 6, inviting stakeholders and the public to submit objections and suggestions within 30 days before finalizing the amendments.
Insights by Ground AI

18 Articles

Lean Right

The central government is going to change some rules related to the manufacture of medicines.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 60% of the sources lean Right
60% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Social News XYZ broke the news on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal